Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotine Gum for Chronic Subjective Tinnitus
NCT07772089Phase 2Completed
- Sponsor
- San Diego State University
- Start
- Mar 2026
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of nicotine polacrilex in chronic subjective tinnitus (2 arms), sponsored by San Diego State University. Primary endpoint: Psychoacoustic Tinnitus Loudness Match at 2 hours. Started Mar 2026; status: completed.
02
Drugs
nicotine polacrilex
03
Conditions
chronic subjective tinnitus
Beyond the preview
Go deeper on NCT07772089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07772089.